OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy with regulatable membrane-bound IL15 (mbIL15) in patients (pts) with immune checkpoint inhibitor (ICI)–resistant advanced melanoma: ...

High-level opening statements Ms. Katja Lasseur, Chair of the fifty-eighth session of the Commission on Population and Development PDF (CPD) Mr. Guy Ryder, Under-Secretary-General for Policy in ...

Cancer researchers now have a comprehensive solution for navigating the complex landscape of tumor-infiltrating lymphocyte (TIL) therapy development, thanks to a new service platform from Creative ...

Advances in immunology are inherently linked to progress in implementing novel methods as best illustrated by the development of the cre-lox technique that allows to analyse the effect of single genes ...

Although adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) has been explored in the treatment of other solid tumors, its potential feasibility and role in nccRCC remains unclear.

The tumor microenvironment plays a key role in tumor development. It consists of immune cells, stromal cells, the extracellular matrix, and blood and lymphatic networks, forming a complex immune ...

“We realized that when cells chose one of their two X chromosomes over the other, they also chose which set of genetic variants to express,” said Matthias Merkenschlager, who leads the Lymphocyte ...

The stages of CLL (chronic lymphocytic leukemia) are based on the Rai and Binet staging systems. Find information about prognosis and staging here.

Low lymphocyte counts may suggest that cancer has spread to your bone marrow, or it can be a side effect of treatments. Lymphoma is a group of cancers that develop in your lymphocytes.